40 results on '"Liu, Jianjun"'
Search Results
2. The superior detection rate of total-body [68Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [68Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy
3. ImmunoPET/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study
4. Exploring the nigrostriatal and digestive interplays in Parkinson’s disease using dynamic total-body [11C]CFT PET/CT
5. Intelligent ultrafast total-body PET for sedation-free pediatric [18F]FDG imaging
6. Uraemia with imbalanced calcium phosphorus metabolism on [68Ga]Ga-FAPI versus [18F]F-FDG PET/CT
7. [68Ga]Ga-FAPI-04 PET/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTs
8. 2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer
9. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
10. Comparison of parametric imaging and SUV imaging with [68 Ga]Ga-PSMA-11 using dynamic total-body PET/CT in prostate cancer
11. ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers
12. Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma
13. Feasibility of acquisitions using total-body PET/CT with a half-dose [68Ga]Ga-FAPI-04 activity in oncology patients
14. Total-body [68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer
15. PET imaging of tumor vascular normalization in hepatocellular carcinoma
16. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
17. Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma
18. [68Ga]Ga-FAPI-04 and [18F]FDG PET/ CT in a patient with MDA5 dermatomyositis
19. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04
20. The feasibility of ultra-early and fast total‑body [68 Ga]Ga-FAPI-04 PET/CT scan
21. Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI
22. PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
23. GPC3-targeted immunoPET imaging of hepatocellular carcinomas
24. Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT
25. 68Ga-FAPI-04 vs. 18F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer
26. 2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer
27. ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053
28. Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT
29. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma
30. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
31. Comparison of parametric imaging and SUV imaging with [68 Ga]Ga-PSMA-11 using dynamic total-body PET/CT in prostate cancer
32. ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers
33. Myofibrosarcoma infiltrating pulmonary arteries diagnosed on 18F-FDG PET/CT
34. Development and characterization of CD54-targeted immunoPET imaging in solid tumors
35. Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer
36. Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI
37. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04
38. The feasibility of ultra-early and fast total‑body [68 Ga]Ga-FAPI-04 PET/CT scan
39. Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT
40. Myofibrosarcoma infiltrating pulmonary arteries diagnosed on 18F-FDG PET/CT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.